Insulet (MEX:PODD) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


MEX:PODD Insulet Corp MEX:PODD
79 GF Score
Price MXN2,548.13
GF Value MXN6,546.87
Valuation Significantly Undervalued
View Full Analysis

What is Insulet Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Insulet's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

MEX:PODD vs MASI, BRKR, GMED: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Insulet's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Insulet Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Insulet's Margin of Safety % (DCF FCF Based) falls into.


MEX:PODD
79GF Score
Insulet Corp MEX:PODD
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Insulet (MEX:PODD) Overvalued in 2026?

Based on GuruFocus' analysis, Insulet stock appears to be undervalued. The current stock price of MXN2,548.13 is trading 61.1% below its estimated GF Value™ of MXN6,546.87. GuruFocus considers Insulet to be Significantly Undervalued.

Key valuation signals for MEX:PODD:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: MXN6,546.87 vs. price of MXN2,548.13 (61.1% below fair value)
  • GF Score™: 79/100

No single metric tells the full story. See the MEX:PODD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Insulet Business Description

Address 100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
79GF Score

Get the complete analysis for MEX:PODD

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,548.13
Price
MXN6,546.87
GF Value